Cytomed Therapeutics Limited (GDTC)

$1.02 +0.07 (7.72%)
Market Cap 11.16M
Revenue (ttm) 50,000.00
Net Income (ttm) -1.84M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,680.00%
Debt to Equity Ratio 0.06
Volume 90,400
Avg Vol 715,956
Day's Range N/A - N/A
Shares Out 10.94M
Stochastic %K 49%
Beta -0.14
Analysts Strong Buy
Price Target $5.00

Company Profile

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a plu...

Industry: Biotechnology
Sector: Healthcare
Phone: 65 6250 7738
Address:
1 Commonwealth Lane, No. 08-22, Singapore, Singapore
chartniko
chartniko Feb. 9 at 10:56 AM
$GDTC is in the cannabis supply chain; it is exposed to the severe pricing pressure and oversupply plaguing the sector, where profitability is elusive and survival depends on cost leadership and access to capital.
0 · Reply
vnukr
vnukr Feb. 8 at 4:54 PM
$GDTC Bears are strongly holding price between 1 $ to 1.19$. Breaking 1.30$ is the key enter…
1 · Reply
vnukr
vnukr Feb. 6 at 8:58 PM
$GDTC what’s going?
1 · Reply
vnukr
vnukr Feb. 6 at 3:19 PM
$GDTC $LIMN Both are having starting problem. Once they get volume, no one stop them…
0 · Reply
vnukr
vnukr Feb. 6 at 3:15 PM
$GDTC Bears are testing Real bulls
0 · Reply
vnukr
vnukr Feb. 6 at 3:12 PM
$GDTC Shorts are pulling shares below VWAP and adding nicely with 5% profit…retailers are losing mony due to stop loss..
0 · Reply
AveraveJoeTrader
AveraveJoeTrader Feb. 6 at 2:19 PM
$GDTC Nice break above the 20 Day MA..let’s see if this can test the 50 next
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 6 at 1:15 PM
$GDTC RSI: 59.31, MACD: -0.1400 Vol: 0.17, MA20: 0.99, MA50: 1.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Feb. 6 at 5:53 AM
$GDTC keep watch if this holds above 1.03
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 6 at 3:03 AM
Fortune Friday Watchlist Pt. 1 $CCHH $MB $GDTC $BULL $ONDS Bull Bounce Time?
0 · Reply
Latest News on GDTC
CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

Oct 2, 2025, 12:02 PM EDT - 4 months ago

CytoMed Therapeutics Limited (GDTC) Q2 2025 Earnings Call Prepared Remarks Transcript

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Oct 2, 2025, 7:00 AM EDT - 4 months ago

CytoMed Therapeutics Announces Publication of Collaborative Research with The University of Texas, MD Anderson Cancer Center, Demonstrating the Potential of Allogeneic γδ T Cells in Acute Myeloid Leukemia

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

Aug 28, 2025, 9:00 AM EDT - 6 months ago

Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Aug 18, 2025, 9:00 PM EDT - 6 months ago

CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

Jul 21, 2025, 10:01 AM EDT - 7 months ago

Update On Clinical Trial Milestone - CytoMed Therapeutics Achieves Completion of Dose Level 1 of its ANGELICA TRIAL, and Proceeding to Dose Level 2 in Patients with Advanced Solid Tumors or Haematological Malignancies

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

Apr 28, 2025, 4:05 PM EDT - 10 months ago

CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Feb 6, 2025, 7:20 AM EST - 1 year ago

CytoMed Therapeutics announces Chairman's Letter to the Company's shareholders

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Jan 6, 2025, 11:10 AM EST - 1 year ago

Singapore-Based CytoMed Therapeutics Stock Dips After SunAct Joins Clinical Trial As Joint Sponsor

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

Aug 20, 2024, 7:00 AM EDT - 1 year ago

Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register Now

CIA CVKD ELUT EUDA GOSS GOVX IMRN

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

Jul 17, 2024, 7:00 AM EDT - 1 year ago

CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (γδ) T Cells Technology for Solid and Liquid Cancers

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

Mar 20, 2024, 8:30 AM EDT - 2 years ago

CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

Mar 18, 2024, 6:00 AM EDT - 2 years ago

CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Mar 4, 2024, 5:00 AM EST - 2 years ago

CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Jan 29, 2024, 7:00 AM EST - 2 years ago

Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

Dec 5, 2023, 7:30 AM EST - 2 years ago

CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

Nov 17, 2023, 9:21 AM EST - 2 years ago

CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Nov 14, 2023, 7:47 AM EST - 2 years ago

CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Oct 24, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Adds to its Intellectual Portfolio After Securing Chinese Patent for its Licensed iPSC-Based Technology

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

Sep 25, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

Sep 1, 2023, 8:00 PM EDT - 2 years ago

CytoMed Therapeutics: An Innovative Immunology Biotech Company To Watch

CytoMed Expands Research Collaboration into China After Entering Into MOU

Aug 29, 2023, 9:00 AM EDT - 2 years ago

CytoMed Expands Research Collaboration into China After Entering Into MOU

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

Aug 20, 2023, 3:50 AM EDT - 2 years ago

Week In Review: Hengrui Out-Licenses Novel Anti-Inflammatory To One Bio In $1 Billion Deal

ARQT SMMT

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

Aug 17, 2023, 7:30 AM EDT - 2 years ago

CytoMed Therapeutics Limited to Present at the August 24th Virtual Investor Summit

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Aug 15, 2023, 1:00 PM EDT - 2 years ago

CytoMed Therapeutics Announces China Research Collaboration to Enhance its Allogeneic CAR γD T In Vivo Persistency

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

Aug 1, 2023, 7:00 AM EDT - 2 years ago

Chinese Patent Granted for A*STAR Spinoff, CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

Jul 27, 2023, 9:00 AM EDT - 2 years ago

CytoMed Therapeutics Announces U.S. Patent Granted For its Licensed, Novel CAR-Gamma Delta T Cell Technology

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

Jul 6, 2023, 7:00 AM EDT - 2 years ago

A*STAR Spinoff CytoMed Therapeutics Announce a Patent for its Licensed CAR-Gamma Delta T Cell Technology Has Been Granted in the US

CytoMed Therapeutics to Ring Nasdaq Closing Bell

May 11, 2023, 9:00 AM EDT - 3 years ago

CytoMed Therapeutics to Ring Nasdaq Closing Bell

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

May 9, 2023, 10:07 AM EDT - 3 years ago

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

Apr 13, 2023, 8:00 PM EDT - 3 years ago

CytoMed Therapeutics Limited Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

Apr 7, 2023, 5:30 AM EDT - 3 years ago

U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week

ARBB ATMU GDHG GMM ISPR KVUE MGIH

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO

Feb 3, 2023, 5:46 PM EST - 3 years ago

IPO Update: CytoMed Therapeutics Aims For $11 Million U.S. IPO

chartniko
chartniko Feb. 9 at 10:56 AM
$GDTC is in the cannabis supply chain; it is exposed to the severe pricing pressure and oversupply plaguing the sector, where profitability is elusive and survival depends on cost leadership and access to capital.
0 · Reply
vnukr
vnukr Feb. 8 at 4:54 PM
$GDTC Bears are strongly holding price between 1 $ to 1.19$. Breaking 1.30$ is the key enter…
1 · Reply
vnukr
vnukr Feb. 6 at 8:58 PM
$GDTC what’s going?
1 · Reply
vnukr
vnukr Feb. 6 at 3:19 PM
$GDTC $LIMN Both are having starting problem. Once they get volume, no one stop them…
0 · Reply
vnukr
vnukr Feb. 6 at 3:15 PM
$GDTC Bears are testing Real bulls
0 · Reply
vnukr
vnukr Feb. 6 at 3:12 PM
$GDTC Shorts are pulling shares below VWAP and adding nicely with 5% profit…retailers are losing mony due to stop loss..
0 · Reply
AveraveJoeTrader
AveraveJoeTrader Feb. 6 at 2:19 PM
$GDTC Nice break above the 20 Day MA..let’s see if this can test the 50 next
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 6 at 1:15 PM
$GDTC RSI: 59.31, MACD: -0.1400 Vol: 0.17, MA20: 0.99, MA50: 1.36 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockScanners
StockScanners Feb. 6 at 5:53 AM
$GDTC keep watch if this holds above 1.03
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 6 at 3:03 AM
Fortune Friday Watchlist Pt. 1 $CCHH $MB $GDTC $BULL $ONDS Bull Bounce Time?
0 · Reply
DayTrade_4Life
DayTrade_4Life Feb. 6 at 1:44 AM
👀Some Stocks to Watch for Friday 6 Feb: WHLR CCHH WOK CETX DXST $GWAV $LIMN $GDTC 🏆Alerts so far this Week in image below. 🔥See Profile and Pinned Post for more info. 💰Live Alerts, Scanner Alerts, Watchlists, Swing Plays, News, Trading Education, Guidance. 👀Join me on X. Link in Profile.
0 · Reply
vnukr
vnukr Feb. 6 at 1:15 AM
$GDTC $LIMN All porums are watching very closely
0 · Reply
vnukr
vnukr Feb. 6 at 12:47 AM
$GDTC Big players will enter any time
0 · Reply
vnukr
vnukr Feb. 6 at 12:46 AM
$GDTC All short shares were completed.. no shares are available for shorting
0 · Reply
vnukr
vnukr Feb. 5 at 11:41 PM
$GDTC Can we expect any positive PR?
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Feb. 5 at 9:53 PM
$TEAD $GDTC $LIMN $GOOG $WXM TEAD — AH Recovery Shorts over extended Google partnership news Float Float Locked (72% Insider)
0 · Reply
Bossbaby14
Bossbaby14 Feb. 5 at 9:12 PM
$WXM $LIMN $GDTC wxm is on the move 👀😅
0 · Reply
IIStock_LesnarII
IIStock_LesnarII Feb. 5 at 9:08 PM
$TEAD $CISS $GDTC $LIMN $TRUG TEAD — AFTER HOURS FUN LET’S PUSH THIS BACK UP TO .75 Super thin on the way up to .71 Fill the gap
0 · Reply
Whiskey1679
Whiskey1679 Feb. 5 at 8:59 PM
$GDTC $MBIO $TDTH
1 · Reply
topstockalerts
topstockalerts Feb. 5 at 8:56 PM
Top Gainers $KELYB $LIMN $CISS $GDTC $SMST
0 · Reply
Stock_Catcher
Stock_Catcher Feb. 5 at 8:50 PM
$GDTC consolidating
0 · Reply
harambe_reborn
harambe_reborn Feb. 5 at 8:48 PM
$GDTC nice little wedge shaping up to end the day watcha gonna do brother
1 · Reply